Fund HoldingsKrensavage Asset Management, LLC

Total Portfolio Value
$271.6K
Total Bought
$12.1K
Total Sold
$34.8K
Net Transaction
-$22.7K
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
EXELIXIS INC(EXEL)2,133,7031,899,151-234,552414115.28%+1
UNITED THERAPEUTICS CORP(UTHR)202,715201,222-1,493454516.73%+1
TARO PHARMACEUTICAL INDUS643,080640,735-2,34524248.90%-0
EAGLE PHARMACEUTICALS INC113,437112,666-771220.65%-0
VANDA PHARMACEUTICALS INC362,951360,429-2,522220.57%-1
KODIAK SCIENCES INC(KOD)344,634342,312-2,322210.23%-2
REGENERON PHARMACEUTICALS(REGN)59,18847,256-11,932433914.32%-4
EMBECTA CORP1,070,8101,164,876+94,06623186.45%-6
ENANTA PHARMACEUTICALS INC687,613735,103+47,4901583.02%-7
CARDINAL HEALTH INC(CAH)353,714291,319-62,39533259.31%-8
BIOGEN INC(BIIB)176,826160,480-16,346504115.19%-9
ALKERMES PLC(ALKS)1,103,451906,060-197,39135259.34%-9
Page 1 of 1